MedPath

Investigating the effect of exercise and green coffee on reducing obesity

Phase 3
Conditions
obesity.
Overweight and obesity
Registration Number
IRCT20170510033909N5
Lead Sponsor
Islamic Azad University, Isfahan Branch (Khorasgan), Research Deputy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Age range of 30 to 35 years
BMI> 30

Exclusion Criteria

Take an intervention to lose weight in the last year
Lack of participation in athletic exercises for at least the last six months
Lack of structural and abnormalities
No history of any Fractures and surgery in the last 1 year
Lack of cardiovascular, renal, hormonal and liver disease
Lack of menopause

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Myonectin. Timepoint: At the beginning and end of the study after 8 weeks. Method of measurement: Serum concentration of Mayonectin by ELISA method using the Hangzhou Sbiofarm manufacturing kit in China.;Methionine-like. Timepoint: At the beginning and end of the study after 8 weeks. Method of measurement: Serum concentration of Mayonectin by ELISA method using the Hangzhou Sbiofarm manufacturing kit in China.
Secondary Outcome Measures
NameTimeMethod
Serum insulin concentration. Timepoint: Before and after intervention. Method of measurement: Serum insulin concentration by ELISA method and use of special kit, Monobind Inc., USA) (75 µg / ml micro-unit per ml, intra-group variation coefficient of 6.3%),.
© Copyright 2025. All Rights Reserved by MedPath